$120.85$150.99
Prepare to embark on a sensory journey with the Bosco Apple, a fruit that transcends the ordinary and promises an unparalleled taste experience. These apples are nothing short of nature’s masterpiece, celebrated for their distinctive blend of flavors and their captivating visual allure.
Availability: In Stock
Subscribe to out newsletter today to receive latest news administrate cost effective for tactical data.
₹660
INTRODUCTION IPCA MMF S TABLET contains Mycophenolate sodium which belongs to the group of medicines called Immunosuppressants. It is used to prevent your body rejecting a transplanted organ (kidney). It is also given with other medications such as corticosteroids and ciclosporin....
IPCA MMF S TABLET contains Mycophenolate sodium which belongs to the group of medicines called Immunosuppressants. It is used to prevent your body rejecting a transplanted organ (kidney). It is also given with other medications such as corticosteroids and ciclosporin.
During treatment with IPCA MMF S TABLET, your doctor might advise you to take regular blood tests to check white blood cell count to assess immunity function of the body.
IPCA MMF S TABLET is not recommended for use if you are allergic to mycophenolic acid, mycophenolate sodium, and mycophenolate mofetil.
It should be used with caution in patients with serious digestive problems (such as stomach ulcer), who are scheduled for vaccination, intolerance to certain sugars (such as lactose, galactose, or glucose), liver problems (such as history of hepatitis B or C), and severe kidney problems.
It is not recommended for use in pregnant and breastfeeding women. IPCA MMF S TABLET is also not recommended for use in children and adolescents (below 18 years of age). Consult your doctor for advice.
It should be used with caution in elderly patients (aged 65 years and above). The most common side effects associated with the use of IPCA MMF S TABLET are bloating, constipation, indigestion, high blood pressure, anxiety, diarrhoea, joint pain and dizziness. Consult your doctor if any of the symptoms worsens.
IPCA MMF S TABLET belongs to immunosuppressants which reduces the action of the body's own defense system (the immune system) and prevents rejection of the transplanted organ.
Take IPCA MMF S TABLET as advised by your physician. Swallow the medicine with a glass of water. Do not crush or chew the medicine. Your doctor will decide the correct dose and duration for you depending upon your age, body weight and disease condition.
Stop taking IPCA MMF S TABLET and contact your doctor if you experience any of the following side effects:
Headache:
Take rest and drink plenty of water. Avoid taking alcohol and skipping meals. Do not strain your eyes by watching screen for long time. Consult your doctor if the symptom does not improve.
Dizziness:
Lie down until the dizziness passes and get up slowly. Do not bend down suddenly. Get a lot of rest. Walk slowly and carefully. Take plenty of fluids. Avoid drinking coffee, alcohol, or smoking. Consult your doctor if the symptom does not improve.
Diarrhoea:
Drink lot of fluids, such as water to keep yourself hydrated. Try to avoid taking any medicine on your own to treat diarrhoea and consult your doctor if the symptom gets worse.
Constipation:
Try to eat more high-fibre foods such as fresh fruit, vegetables, cereals, and drink plenty of water. Try doing exercise regularly (going for a daily walk or run). If this does not help, inform your doctor for receiving alternate treatment for constipation.
Nausea and Vomiting:
Try to take IPCA MMF S TABLET with or just after a meal or a snack. Stick to simple meals. Avoid eating oily, fried or spicy foods. Do not lie down or sleep immediately after eating. Consult your doctor if the symptom gets worse.
IPCA MMF S TABLET is not recommended for use during pregnancy and in women planning to become pregnant. Women with childbearing potential should confirm with negative in pregnancy test and follow effective contraception before taking IPCA MMF S TABLET to avoid birth defects and miscarriage. Consult your doctor before taking IPCA MMF S TABLET.
IPCA MMF S TABLET is not recommended for use in breastfeeding women as it can pass into the breast milk. Consult your doctor taking IPCA MMF S TABLET.
IPCA MMF S TABLET has no or negligible effect on your ability to drive and use machines. Consult your doctor before taking IPCA MMF S TABLET.
IPCA MMF S TABLET should be used with caution in patients with severe kidney problems. Consult your doctor before taking IPCA MMF S TABLET.
IPCA MMF S TABLET should be used with caution in patients with a history of hepatitis B or C (liver infection). Consult your doctor before taking IPCA MMF S TABLET.
Do not take IPCA MMF S TABLET if you are allergic (hypersensitive) to Mycophenolate sodium or to some sugars such as lactose, galactose, or glucose or to other ingredients of this medicine.
IPCA MMF S TABLET should be used with caution in patients with lung diseases. Contact your doctor before taking IPCA MMF S TABLET.
IPCA MMF S TABLET is not recommended for use if you:
Before taking IPCA MMF S TABLET, inform your doctor if you:
Use in pediatrics:
IPCA MMF S TABLET is not recommended for use in children due to lack of data. Consult child’s doctor for advice.
Use in geriatrics:
IPCA MMF S TABLET should be used with caution in elderly patients (aged 65 years and above). Consult your doctor before taking IPCA MMF S TABLET.
A. Drug-Drug Interactions:
Before taking IPCA MMF S TABLET, inform your doctor, if you are taking any of the following medicines:
Overdosage:
If you or anyone else accidentally takes too much of IPCA MMF S TABLET, consult your doctor immediately or visit the nearby hospital.
| Drug | : | Mycophenolate sodium |
| Pharmacological Category | : | Immunosuppressants |
| Therapeutic Indication | : | Prevents your body from rejecting a transplanted organ |
| Dosage Forms | : | Tablet, Capsule, Suspension, Oral suspension |
What is IPCA MMF S TABLET used for?
IPCA MMF S TABLET is used alone or with other medicines containing ciclosporin and corticosteroids to stop the body’s immune system from rejecting a kidney transplant in transplanted individuals.
What common side effects are seen with IPCA MMF S TABLET?
The most common side effects associated with the use of IPCA MMF S TABLET are bloating, constipation, indigestion, high blood pressure, anxiety, diarrhoea, pain in joints, and dizziness. Consult your doctor if any of the symptom worsens.
Who should avoid taking IPCA MMF S TABLET?
IPCA MMF S TABLET is not recommended for use if you are allergic to mycophenolic acid, mycophenolate sodium, and mycophenolate mofetil. IPCA MMF S TABLET is also not recommended for use in pregnant and breast-feeding women. Consult your doctor before taking IPCA MMF S TABLET.
How IPCA MMF S TABLET works?
IPCA MMF S TABLET belongs to immunosuppressants which reduces the action of the body's own defense system (the immune system) and prevents rejection of the transplanted organ.
What happens if I forget to take IPCA MMF S TABLET dose?
You should take IPCA MMF S TABLET immediately when you remember. If it is time for your next dose skip the missed dose and follow your regular dose schedule. Do not double the dose of IPCA MMF S TABLET to match up your missed dose.
Is IPCA MMF S TABLET safe to use in children or elderly patients?
No, IPCA MMF S TABLET is not recommended for use in children due to lack of data. It should be used with caution in elderly patients (aged 65 years and above) after consulting the doctor.
Is IPCA MMF S TABLET safe to use during pregnancy?
IPCA MMF S TABLET is not recommended for use during pregnancy and in women planning to become pregnant. Women with childbearing potential should confirm with negative in pregnancy test and follow effective contraception before taking IPCA MMF S TABLET to avoid birth defects and miscarriage. Consult your doctor before taking IPCA MMF S TABLET.
1. Giuseppe Orlando, Giuseppe Remuzzi, David F. Williams. Pharmacokinetics and Genomics of Immunosuppressive Drugs. Kidney Transplant, Bioengineering, and Regeneration; Kidney Transplantation in Regenerative Medicine Era. 2017. Page 429.
2. Novartis. Efficacy and Safety Study of Everolimus Plus Reduced Cyclosporine Versus Mycophenolic Acid Plus Cyclosporine in Kidney Transplant Recipients. NIH U.S. National Library of Medicine ClinicalTrials.gov. [Revised in May 2011] [Accessed on 8th August 2022] https://clinicaltrials.gov/ct2/show/NCT00251004
3. Dela Golshayan, M Pascual, Bruno Vogt. Mycophenolic acid formulations in adult renal transplantation – update on efficacy and tolerability. NIH National Library of Medicine. National Center for Biotechnology Information. May 2009. [Accessed on 8th August 2022] https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2690976
4. Novartis Pharma GmbH. Electronic Medicines Compendium (EMC). [Revised in July 2021] [Accessed on 8th August 2022] https://www.medicines.org.uk/emc/files/pil.7793.pdf
5. Concord Biotech Limited. Mofecon-S 540. [Accessed on 8th August 2022] https://www.concordbiotech.com/product-3/#1491386049532-0521ba85-12e0
Written By Dr. Janet.C, Pharm.D
Last updated on 12 Nov 2022 | 04:04 PM(IST)